Showing results (1351-1360 of 3,156) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|February 8, 2021
Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM studyThomas Graillon, Loic Ferrer, Jason Siffre, et al.
Neuro-Oncology|February 18, 2021
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patientsLinda Dirven, Jammbe Z Musoro, Corneel Coens, et al.
Neuro-Oncology|January 28, 2021
Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classificationCecile L Maire, Marceline M Fuh, Kerstin Kaulich, et al.
Neuro-Oncology|February 25, 2021
DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological featuresMaritza S Mosella, Thais S Sabedot, Tiago C Silva, et al.
Neuro-Oncology|February 25, 2021
Height in adolescence as a risk factor for glioma subtypes: a nationwide retrospective cohort study of 2.2 million subjectsRoi Tschernichovsky, Lior H Katz, Estela Derazne, et al.
Neuro-Oncology|February 5, 2021
Longitudinal change in fine motor skills after brain radiotherapy and in vivo imaging biomarkers associated with declineMia Salans, Michelle D Tibbs, Roshan Karunamuni, et al.
Neuro-Oncology|December 21, 2016
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813Susan Chang, Peixin Zhang, J Gregory Cairncross, et al.
Neuro-Oncology|April 25, 2014
MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapyShahrzad Jalali, Caroline Chung, Warren Foltz, et al.
Neuro-Oncology|December 8, 2016
Metadherin/Astrocyte elevated gene-1 positively regulates the stability and function of forkhead box M1 during tumorigenesisLixuan Yang, Kejun He, Sheng Yan, et al.
Neuro-Oncology|February 16, 2017
Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasisVanda Téglási, Lilla Reiniger, Katalin Fábián, et al.
Pageof 316